Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) 6.3% LOWER; intends to offer for sale its common stock in an underwritten public offering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE